Soler María José, Lloveras Josep, Batlle Daniel
Departamento de Nefrología, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, España.
Med Clin (Barc). 2008 Jul 12;131(6):230-6. doi: 10.1157/13124619.
The renin-angiotensin system (RAS) plays a key role in the regulation of cardiovascular and renal function. Thus, RAS blockade with an angiotensin-converting enzyme (ACE) and/or angiotensin receptor blocker decreases blood pressure, cardiovascular events, and delays the progression of kidney disease. The discovery of ACE2, a homologue of ACE, capable of degrading angiotensin II to angiotensin 1-7, may offer new insights into the RAS. In this review we discuss the possible protective role of ACE2 in different organs, namely heart, lungs and kidneys. The role of this enzyme is inferred from recent studies performed using genetically manipulated mice that lack the ACE2 gene and also mice treated with pharmacological ACE2 inhibitors. These results suggest that ACE2 might be a new therapeutic target within the RAS.
肾素-血管紧张素系统(RAS)在心血管和肾功能调节中起关键作用。因此,使用血管紧张素转换酶(ACE)抑制剂和/或血管紧张素受体阻滞剂阻断RAS可降低血压、减少心血管事件并延缓肾脏疾病进展。ACE2作为ACE的同源物,能够将血管紧张素II降解为血管紧张素1-7,其发现可能为RAS提供新的见解。在本综述中,我们讨论了ACE2在不同器官(即心脏、肺和肾脏)中可能的保护作用。该酶的作用是从最近使用缺乏ACE2基因的基因工程小鼠以及用药物性ACE2抑制剂治疗的小鼠所进行的研究中推断出来的。这些结果表明,ACE2可能是RAS内的一个新的治疗靶点。